Cutaneous manifestations in COVID-19: Lessons learned from current evidence

J Am Acad Dermatol. 2020 Jul;83(1):e57-e60. doi: 10.1016/j.jaad.2020.04.094. Epub 2020 Apr 24.

Authors

Poonkiat Suchonwanit¹, Kanchana Leerunyakul², Chaninan Kositkuljorn²

Affiliations

¹ Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Electronic address: poonkiat@hotmail.com.
² Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

No abstract available

Publication types

Letter

MeSH terms

Antiviral Agents / adverse effects*
Betacoronavirus / immunology*
Betacoronavirus / isolation & purification
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / drug therapy
Coronavirus Infections / epidemiology
Coronavirus Infections / immunology
Diagnosis, Differential
Drug Eruptions / diagnosis*
Exanthema / diagnosis*
Exanthema / immunology
Exanthema / virology
Humans
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / drug therapy
Pneumonia, Viral / epidemiology
Pneumonia, Viral / immunology
SARS-CoV-2
Urticaria / diagnosis*
Urticaria / immunology
Urticaria / virology

Substances

Antiviral Agents